The CTSB–CREG1 axis explains at least in part the frequently reported tumor attenuation upon CTSB knock-out or inhibition in MMTV-PyMT breast cancers and other cancer models (Fig. 11e). This evidence concerns the gene CREG1 and breast cancer.